
Keywords: HIV; Human Immunodeficiency Virus; CYP; Cytochrome P450; TKI; tyrosine kinase inhibitor; P-gp; P-glycoprotein; OATP; Organic Anion Transporting Polypeptide; INR; International Normalized Ratio; Drug-food interactions; Clinical practice; Cytochrome P450 3A